ConvaTec Group PLC Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/18/2026)
| Balance Sheet | Total Assets | 2,808,419,010.79 | ROE | 40.15 % |
| Balance Sheet | Total Equity | 1,127,527,124.02 | ROA | 6.36 % |
| Cashflow | Capital Expenditures | -102,340,654.74 | P/FCF | 18.55 |
| Cashflow | Free Cash Flow | 253,956,426.06 | – | – |
| Cashflow | Operating Cash Flow | 356,297,080.80 | P/CF | 13.23 |
| Income | Earnings per Share (diluted) | 0.09 | Div. Yield | 2.13 % |
| Income | Net Income | 132,787,990.92 | P/E | 26.07 |
| Income | Shares Outstanding | 2,008,537,000.00 | P/B | 4.18 |
| Income | Total Revenue | 2,439,000,000.00 | P/S | 2.55 |
Ratios calculated on: 10/14/2026
Company Description
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets. Its products include FlexiSeal Signal, FlexiSeal Fecal Collector and Intermittent Catheters.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.convatecgroup.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more